Stocks and Investing
Stocks and Investing
Fri, May 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Peter Lawson Initiated (BMEA) at Buy and Held Target at $50 on, May 12th, 2023
Peter Lawson of Barclays, Initiated "Biomea Fusion, Inc." (BMEA) at Buy and Held Target at $50 on, May 12th, 2023.
Peter has made no other calls on BMEA in the last 4 months.
There are 5 other peers that have a rating on BMEA. Out of the 5 peers that are also analyzing BMEA, 0 agree with Peter's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Peter
- Michael King of "EF Hutton" Reiterated at Strong Buy with Decreased Target to $32 on, Thursday, May 4th, 2023
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $37 on, Wednesday, May 3rd, 2023
- Hartaj Singh of "Oppenheimer" Reiterated at Buy and Held Target at $47 on, Tuesday, April 11th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $55 on, Friday, April 7th, 2023
- Joseph Catanzaro of "Piper Sandler" Maintained at Buy with Increased Target to $40 on, Tuesday, March 28th, 2023
Contributing Sources